ESMOPRAG-DSR
ESMOPRAG-DSR
Esmopra-DSR Capsules – Advanced Dual Action Therapy for Acid Management
Esmopra-DSR Capsules combine the powerful acid-suppressing action of Esomeprazole with the gastrointestinal motility support of Domperidone SR to provide effective and long-lasting relief from acid-related disorders. Designed as a first-line therapy for acid management, this formulation helps reduce stomach acid, improve digestion, and relieve discomfort associated with reflux and gastric irritation.
Composition
- Esomeprazole 40 mg
- Domperidone 30 mg SR (Sustained Release)
Key Benefits
- Effective first-line therapy for acid-related disorders
- Dual-action formula for enhanced symptom relief
- Provides long-lasting comfort from acidity and reflux
- Helps reduce acid production and gastric irritation
- Supports better gastric motility and digestion
- Well-tolerated formulation with effective therapeutic response
Indications
Esmopra-DSR Capsules are commonly indicated for:
- GERD (Gastroesophageal Reflux Disease)
- Gastritis
- Gastric & Duodenal Ulcers
- Erosive Esophagitis
- Acid Reflux & Heartburn
Dual Action Formula
Esomeprazole is a proton pump inhibitor (PPI) that effectively reduces stomach acid secretion, helping heal acid-related damage and prevent recurrent acidity. Domperidone SR improves gastric motility and helps relieve symptoms such as bloating, nausea, and reflux discomfort.
Esmopra-DSR by Harksun delivers reliable and comprehensive acid management for improved digestive comfort and long-term relief from acid-related conditions.